GlassScriptPhysician profile
Sarah C James
NPI 1831347913
$2,533.08
in general payments reported to CMS, 2019-2025
15 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $328 · 2022: $475 · 2023: $578 · 2024: $680 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,710 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,709.78 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $475.51 | 2021-2025 | Farxiga, Wainua, Lokelma |
| Amgen INC. | $410.35 | 2022-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.09 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $285.49 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $231.05 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $227.12 | 2022-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $221.37 | 2021-2023 | Verquvo |
| Esperion Therapeutics, INC. | $124.50 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $86.28 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $69.81 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $24.75 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $22.30 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $17.48 | 2025 | Camzyos |
| Kowa Pharmaceuticals America, INC. | $16.52 | 2021 | |
| Pfizer INC. | $13.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.